Last month, CMS released a list of the first 10 drugs that will be eligible for Medicare price negotiations under the Inflation Reduction Act (IRA). And while these government negotiations may create a “spill-over” effect and allow employers to also negotiate better prices, others worry they may end up increasing costs for commercial health plans […]
